Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 1999, p. 1542-1548, Vol. 43, No. 7
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Salt-Resistant Alpha-Helical Cationic
Antimicrobial Peptides
Carol
Friedrich,
Monisha G.
Scott,
Nedra
Karunaratne,
Hong
Yan, and
Robert E. W.
Hancock*
Department of Microbiology and Immunology,
University of British Columbia, Vancouver, British Columbia V6T
1Z3, Canada
Received 2 November 1998/Returned for modification 30 January
1999/Accepted 9 April 1999
 |
ABSTRACT |
Analogues based on the insect cecropin-bee melittin hybrid peptide
(CEME) were studied and analyzed for activity and salt resistance. The
new variants were designed to have an increase in amphipathic
-helical content (CP29 and CP26) and in overall positive
charge (CP26). The
-helicity of these peptides was demonstrated by
circular dichroism spectroscopy in the presence of liposomes. CP29 was
shown to have activity against gram-negative bacteria that was
similar to or better than those of the parent peptides, and CP26 had
similar activity. CP29 had cytoplasmic membrane permeabilization activity, as assessed by the unmasking of cytoplasmic
-galactosidase, similar to that of CEME and its more positively
charged derivative named CEMA, whereas CP26 was substantially less
effective. The activity of the peptides was not greatly attenuated by
an uncoupler of membrane potential, carbonyl
cyanide-m-chlorophenylhydrazone. The tryptophan residue in
position 2 was shown to be necessary for interaction with
cell membranes, as demonstrated by a complete lack of activity in the
peptide CP208. Peptides CP29, CEME, and CEMA were resistant to
antagonism by 0.1 to 0.3 M NaCl; however, CP26 was resistant to
antagonism only by up to 160 mM NaCl. The peptides were generally
more antagonized by 3 and 5 mM Mg2+ and
by the polyanion alginate. It appeared that the positively charged
C terminus in CP26 altered its ability to permeabilize the
cytoplasmic membrane of Escherichia coli, although
CP26 maintained its ability to kill gram-negative bacteria.
These peptides are potential candidates for future therapeutic drugs.
 |
INTRODUCTION |
Antimicrobial cationic
peptides are ubiquitous in nature and are thought to be
components of the first line of defense against infectious agents
(16). There are four structural classes of cationic
peptides: the disulfide-bonded
-sheet peptides, including the
defensins; the amphipathic
-helical peptides, such as the cecropins
and melittins; extended peptides which often have a single amino acid
predominating, e.g., indolicidin; and the loop-structured peptides,
like bactenecin (16). Initial interactions of some cationic
peptides with gram-negative bacteria are thought to involve binding to
surface lipopolysaccharide (LPS) (28, 31). The peptides
displace divalent cations that are essential for outer membrane
integrity and consequently distort the outer membrane bilayer
(26). This allows access to the cytoplasmic membrane, where
peptide channel formation has been proposed to occur (21). It is increasingly disputed as to whether peptide channel formation leads to dissolution of the proton motive force and the leakage of
essential molecules (9, 19, 37) or whether it is an intermediate step in the uptake of peptide into the cytoplasm, where it
inhibits essential functions, e.g., by binding to polyanionic DNA
(38).
Cecropins were originally isolated from the immune hemolymph of the
North American silk moth Hyalophora cecropia
(17). Cecropins have been well studied and characterized
with respect to structure and function (12). Based on model
membrane studies, the broad spectrum of antimicrobial activity of
cecropins has been attributed to its ability to form large pores in
bacterial cell membranes (8). A series of hybrid peptides
were created, consisting of the amphipathic
-helical N-terminal
region of cecropin A and the hydrophobic N-terminal
-helix of the
bee venom peptide melittin (35). These hybrids
form ion-permeable channels in model lipid membranes
(36). To understand the structure-function relationships of
these peptides, analogues based on the cecropin (1-8)-melittin (1-18)
hybrid (CEME) were studied. The general conclusions from these studies
were that the analogues should have a hydrophilic domain and a
hydrophobic domain linked by a hinge region (7). A hinge
region provides conformational flexibility due to the presence of
glycine and proline residues (4). The aromatic residue at
position 2 and the
-helical region in the first 11 amino acids have
been found to be necessary for antimicrobial action (3).
Piers et al. (27) further modified the hybrid peptide CEME
(also called MBI-27 [14]) by adding two extra
positively charged residues to the C terminus in order to assess the
role of ionic charges in interactions with bacteria. The resulting peptide, CEMA (also called MBI-28 [14]), had MICs
similar to those of CEME but had an increased ability to permeabilize
the outer membranes of gram-negative bacteria and an increased affinity for LPS.
Pseudomonas aeruginosa is a pathogen that is known to
colonize the lungs of cystic fibrosis patients. It is believed that the
increased salinity of the bronchopulmonary fluids in these patients
decreases the efficacy of endogenous cationic peptides of epithelial
surfaces, thereby allowing colonization by these bacteria (13,
34). It is because of this that there is an interest in
salt-resistant cationic peptides. Lee et al. (20) reported
that clavanins,
-helical peptides that derive their cationicity from
histidine residues, function in environments with normal and elevated
levels of NaCl. This is in contrast to magainin, an
-helical peptide
that is susceptible to the presence of 100 mM NaCl (20). In
this study we looked at the resistance to the antagonistic effects of
salt, the antimicrobial activity, and the mechanism of action of a
family of related CEME variants designed here to be slightly different
in charge, length, and hydrophobicity and to conform to Edmundson
helical-wheel projections (32).
 |
MATERIALS AND METHODS |
Materials and bacterial strains.
All peptides were
synthesized by N-(9-fluorenyl)methoxycarbonyl chemistry
at the Nucleic Acid/Protein Service unit at the University of British
Columbia. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phophoglycerol
(POPG) were purchased from Northern Lipids Inc. (Vancouver, British
Columbia, Canada).
o-Nitrophenyl-
-D-galactopyranoside (ONPG) and
carbonyl cyanide-m-chlorophenylhydrazone (CCCP) were
purchased from Sigma Chemical Co. (St. Louis, Mo.). Bovine serum
albumin fraction V lyophilisate was purchased from Boehringer Mannheim
(Mannheim, Germany).
Strains used for determining antimicrobial activity included P. aeruginosa PAO1 (15) as well as some
antibiotic-resistant strains. P. aeruginosa K385 and
1008OCR01 (nfxB and nalB mutants, respectively)
are strains that overproduce specific efflux pumps, resulting in
resistance to antibiotics such as norfloxacin (29), cephems,
and quinolones (22). P. aeruginosa PAO963 has the
nalA phenotype due to a mutation in the locus encoding a DNA
gyrase subunit, resulting in nalidixic acid resistance (18,
30). A
-lactamase-derepressed strain (PA-83-48) (6)
and an antibiotic-supersusceptible strain (Z61) (5) were
also used. Escherichia coli UB1005 and Salmonella
typhimurium 14028s and its defensin-supersusceptible phoP
phoQ derivative S. typhimurium MS7953s (11)
were also used to determine peptide MICs. E. coli ML35, a
lactose permease-deficient strain with constitutive cytoplasmic
-galactosidase activity, was used in the cytoplasmic membrane
permeabilization assay (21). Mueller-Hinton (MH) broth was
used as the general growth medium for all studies reported here.
Preparations of liposomes.
A chloroform solution of lipid
(POPC-POPG, 7:3) was mixed with peptides dissolved in methanol. This
solution was dried under a stream of N2 in a vacuum to
remove the solvent. The resulting lipid-peptide film was rehydrated in
10 mM phosphate buffer (pH 7.0). The suspension was put through five
cycles of freeze-thawing to produce multilamellar liposomes, followed
by extrusion through 0.1-µm-pore-size double-stacked Poretics
membrane filters (AMD Manufacturing Inc., Mississauga, Canada) with an
extruder device (Lipex Biomembranes, Vancouver, British Columbia,
Canada). A fraction of these liposomes were further extruded with
0.05-µm-pore-size double-stacked Poretics membrane filters.
CD.
Circular dichroism (CD) spectra were measured with a
J-720 spectropolarimeter (Jasco, Tokyo, Japan) connected to a Jasco
data processor. All samples were in 10 mM sodium phosphate buffer (pH 7.0) and measured in a quartz cell with a 1-mm path length at room
temperature. The scanning speed was 10 nm/min (190 to 250 nm), and
each spectrum obtained is the average of five scans. The CD spectrum of
liposomes alone was subtracted from that of the peptide with liposomes
to compensate for light scatter. The
-helical content of the
peptides was estimated by the K2D program (2).
MIC.
The MIC of each peptide was determined by using a broth
dilution assay modified from the method of Amsterdam (1).
Briefly, serial dilutions of each peptide were made in 0.2% bovine
serum albumin-0.01% acetic acid solution in 96-well polypropylene
(Costar, Corning Incorporated, New York, N.Y.) microtiter plates. Each well was inoculated with 100 µl of the test organism in MH broth to a
final concentration of 2 × 104 to 105
CFU/ml. The MIC was taken as the lowest peptide concentration at which
growth was inhibited after 18 h of incubation at 37°C. Where
indicated, fixed concentrations of NaCl, MgCl2, or sodium alginate (Sigma) were added to each well of the microtiter plate.
Bacterial killing assays.
An overnight culture of E. coli UB1005 was diluted 10
2 in fresh MH broth and
allowed to grow to logarithmic (optical density at 600 nm
[OD600] of 0.6) or stationary (OD600 of 2.0)
phase and then diluted in fresh medium, yielding a working
concentration of 108 cells/ml. The peptides or antibiotics
were added at four times their MICs, and these suspensions were
incubated at 37°C. At regular intervals after peptide addition,
samples were removed, diluted, and plated onto MH agar plates to obtain
a viable count.
Cytoplasmic membrane permeabilization assay.
The
permeabilization of the cytoplasmic membrane of E. coli ML35
by the peptides was determined by their ability to unmask cytoplasmic
-galactosidase to permit hydrolysis of the normally non-membrane-permeative chromogenic substrate ONPG (21).
Log-phase bacteria were washed in 10 mM sodium phosphate buffer (pH
7.4). The cells were resuspended in the same buffer with 1.5 mM ONPG. The production of o-nitrophenol over time was monitored
spectrophotometrically at 420 nm after the addition of the peptide at
four times the MIC (4 µg/ml) or 12.8 µg/ml in the case of CP201 and
CP208. This assay was also done in the presence of 100 mM NaCl, 5 mM
MgCl2, or 100 µM CCCP.
Animal model.
P. aeruginosa infections of neutropenic
mice and protection experiments with antimicrobial peptides were
performed exactly as described previously (14).
 |
RESULTS |
Peptide design and secondary structure.
In previous studies we
had examined the cecropin-melittin hybrid CEME and its variant CEMA.
The CEME sequence was modified to increase the
-helical content in
the first 14 amino acids, resulting in CP29, using the Edmundson
helical-wheel projection (32) to design this and the other
peptides described here. This involved substituting hydrophilic amino
acids for residues 4, 8, 10, 11, and 14, while residues 6 and 9 were
replaced with hydrophobic amino acids. The maintenance of cationic
charge was achieved by placing lysine residues at positions 8 and 14. Another related peptide, CP26, had the same first 10 residues as CP29,
but the C terminus was predicted to be more hydrophilic because of the addition of an extra positively charged lysine. CP201 was very similar
to CP29, with the exception of the flexible hinge region consisting of
two glycines in the center of the peptide. CP208 was similar to CP26,
with four amino acid replacements, including the replacement of the
tryptophan at position 2 with a lysine. In general, these peptides had
only slight differences in charge, length, and hydrophobicity (Table
1).
CD spectra were measured in 10 mM sodium phosphate buffer in the
presence and absence of POPC-POPG (7:3) liposomes, as well
as in the
membrane-mimicking environments provided by the addition
of sodium
dodecyl sulfate (SDS) and trifluoroethanol (TFE; also
considered a
helix-inducing solvent). The concentrations of peptide
and lipid in the
buffer were 50 µM and 2 mM, respectively. In
buffer, all peptides
exhibited spectra characteristic of unordered
structure. The spectra of
CP26, CEME, CEMA, CP29, and CP201 in
the presence of liposomes
showed the typical appearance of

-helix-rich
structures, with
minimal mean residue molar ellipticity values
at 207 and 222 nm
(Fig.
1). The spectrum of CP208 was
essentially
that of a random coil. Similar spectra were obtained with
both
60- and 90-nm-diameter liposomes, indicating that light scattering
by the liposomes did not affect these results. An estimate of
percent

-helicity in the various solutions was obtained with
the K2D
algorithm (
2) (Table
2). This
program predicted that
the peptides contained only

-helix or
random-coil secondary structures
and no

-sheet structures. In
general, CP29 appeared to have the
most

-helical structure in the
presence of liposomes (approximately
50%); CEMA, CP26, and CP29 were
about one-third

-helix; and CP201
and especially CP208 failed to
become substantially

-helical.
Most researchers have examined

-helicity not in the presence
of liposomes but rather in the
so-called membrane-mimicking solvents
TFE and SDS. Generally speaking,
these solvents also revealed
that the peptides were

-helical,
but the relative

-helicities
varied among the different
peptides. For example, in SDS, CP208
was as

-helical as CP29. This
stresses the importance of the
microenvironment in peptide structure
formation.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 1.
CD spectra of cationic peptides in the presence of 90-nm
liposomes (POPC-POPG, 7:3) and CP26 in phosphate buffer (random coil).
The peptides are represented as follows: CP201, round dots; CP208,
solid lines; CEMA, dash-dots; CEME, long dashes; CP26, dashes; and
CP29, square dots.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
-Helicity in various environments as assessed by CD
spectroscopy interpreted according to the K2D algorithm (2)
|
|
Antimicrobial activity.
The MICs of the peptides for selected
gram-negative bacteria are shown in Table
3. The MIC was taken as the lowest
peptide concentration at which growth was inhibited in a broth dilution assay. CP26 and CP29 were similar in activity to CEMA and CEME. It was
of interest to determine if mutations influencing susceptibility to
conventional antibiotics had an effect on peptide MICs, especially given the recent observation by Shafer et al. (33) that
peptides are influenced by multidrug efflux pathways in
Neisseria. Neither nalB nor nfxB,
which result in multidrug resistance due to derepression of the MexA
MexB OprM and MexC MexD OprJ efflux pathways, respectively, had much
effect on peptide MICs. Similarly, little effect was observed for
mutants representing the relatively common clinical mutations in
DNA gyrase (nalA) or derepression of
-lactamase or
the laboratory-derived mutations in Z61 which make the strain supersusceptible to virtually all conventional antibiotics due to outer
membrane permeability and efflux defects. Of the other peptides, CP201
had intermediate activity and CP208 had little to no activity against
the bacteria tested.
The best peptides demonstrated modest antimicrobial activity in an
animal model. Neutropenic mice (8 to 12 per group) were
injected
intraperitoneally with 200 to 300
P. aeruginosa M2 cells,
leading to 8% survival in control (saline-injected) animals.
Intraperitoneal
injection, 30 min after the injection of bacteria, of a
single
dose of 200 µg of CP26 or CP29 led to identical (37%)
survival
rates after 4 days (
P < 0.05 by Fisher's
exact test), results
comparable to those achieved by CEME (26.7%) and
CEMA (43.3%)
(
14).
Antimicrobial activity in the presence of salts.
The MICs of
the most active peptides for P. aeruginosa were determined
in the presence of NaCl, MgCl2, and sodium alginate (Table
4). There was no significant increase in
the MICs of CP29, CEME, or CEMA in the presence of 300 mM NaCl, whereas
CP26 showed a 16-fold increase in MIC under those conditions. However,
CP26 was still resistant (less than a twofold increase in MIC; data not
shown) to NaCl antagonism at a NaCl concentration up to 160 mM. The
concentration of NaCl in the epithelial cell secretions of a cystic
fibrosis patient is about 120 mM (13), and at this concentration all peptides maintained good anti-Pseudomonas
activity.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Influence of NaCl, MgCl2, and polyanionic
alginate on MICs of cationic antimicrobial peptides for
P. aeruginosa PAO1
|
|
The antibacterial activities of CP26, CP29, and CEME were more affected
by the presence of divalent cations. At 3 mM MgCl
2 (modeling the serum divalent-cation concentrations of 1 mM
Mg
2+ and 2 mM Ca
2+) (
1), there was a
four- to eightfold increase in MICs. Since
the concentration of added
Cl

in this case was only 6 mM, and 100 mM
Cl

had virtually no effect on MIC in the form of NaCl, it
was concluded
that the increase in MICs was due to the divalent cation
Mg
2+. In contrast to these three peptides, CEMA appeared to
be relatively
resistant to serum divalent-cation concentrations of 3 mM, but
not 5 mM, Mg
2+. Sodium alginate, a polyanionic
polysaccharide related to the
mucous exopolysaccharide of
P. aeruginosa and intended to be representative
of polyanions and
polysaccharides present in vivo, antagonized
the activities of CEME and
CEMA more than those of CP26 and CP29.
This effect was probably due to
the alginate anion, not the sodium
cation. CEMA, which was the most
resistant to divalent cations,
was the most sensitive to
alginate.
Killing assays.
We assessed the ability of the peptides at
four times their MICs to kill logarithmic- and stationary-phase
E. coli UB1005 in MH medium (Fig. 2A and
B, respectively). The peptides killed logarithmic-phase E. coli rapidly by 3 to 5 log orders
within 5 min. After 20 min, CP29 and CEME had reduced the number of
log-phase bacteria by a total of 6 log orders, whereas CP26 and CEMA
showed little reduction after the initial 3-log reduction, although all four peptides had similar MICs for E. coli. In contrast, the
conventional antibiotics cationic aminoglycoside gentamicin and
-lactam ceftazidime induced only 2 and 1 log order of killing,
respectively. Stationary-phase bacteria in MH broth were killed in a
manner similar to log-phase bacteria, with the exception that the
kinetics of killing was considerably slower (and for CP29 appeared
biphasic) except for CEMA. CP26 (not shown for clarity) was only as
efficient at killing as ceftazidime, but the other peptides were more
effective than the conventional antibiotics.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Survival of logarithmic-phase (A) and stationary-phase
(B) E. coli UB1005 in MH broth after addition of fourfold
the MIC of peptide, gentamicin, or ceftazidime. This corresponds to 2 µg of CP26, CP29, and ceftazadime per ml, 4 µg of CEME and CEMA per
ml, and 0.5 µg of gentamicin per ml. Actual initial concentrations of
bacteria ranged from 0.5 × 108 to 2.5 × 108/ml but were corrected to an initial concentration of
1 × 108/ml for clarity. A typical experiment out of
three trials is shown. Symbols: , no peptide; , CP26; , CP29;
, CEME; , CEMA; , ceftazidime; , gentamicin. Results for
CP26 in panel A were almost superimposable with the ceftazidime results
and were thus omitted for clarity. No evidence of bacterial aggregation
was observed when viewed under a light microscope or in
light-scattering experiments.
|
|
Cytoplasmic membrane permeabilization assay.
The extent
of cytoplasmic membrane permeabilization by peptides (at fourfold
their MICs) is indicated by the hydrolysis of the chromogenic
substrate ONPG by the cytoplasmic enzyme
-galactosidase. The
hydrolysis of ONPG was measured spectrophotometrically (Fig. 3). For CEME, CEMA, and CP29,
permeabilization was rapid and reached a maximal rate within 1 min. CP26, however, had a considerably lower rate of permeabilization
and took 14 min to reach the same level of ONPG hydrolysis as the other
three peptides reached in 4 min. CP201 (at threefold its MIC)
permeabilized the membrane at a low rate similar to that of another
cationic antimicrobial, the lipopeptide polymyxin B, whereas CP208 (at
12.8 µg/ml) demonstrated little to no permeabilizing ability.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3.
Permeabilization of cytoplasmic membrane of E. coli ML35 by cationic peptides as determined by their ability to
unmask cytoplasmic -galactosidase. The hydrolysis of ONPG was
measured spectrophotometrically at 420 nm. Symbols: , CP26 at 12.8 µg/ml; , CEME at 6.4 µg/ml; , CEMA at 6.4 µg/ml; , CP29
at 6.4 µg/ml; , polymyxin B at 12.8 µg/ml; , CP201 at 12.8 µg/ml; , CP208 at 12.8 µg/ml.
|
|
The influence of various factors on cytoplasmic membrane
permeabilization was tested for CEME, CP26, and CP29 (Fig.
4). The
peptides maintained their
abilities to permeabilize the cytoplasmic
membrane of
E. coli in the presence of NaCl, although CP29 was
somewhat more
effective. However, in the presence of 5 mM Mg
2+, all
peptides were affected, and the most salt-sensitive peptide,
CP26, lost
its ability to permeabilize the cytoplasmic membrane.
The peptides were
not highly affected by the presence of the uncoupler
CCCP at high
concentrations, indicating that these peptides can
still exert their
effects in the absence of a membrane potential,
in contrast to, e.g.,
the indolicidins (
10).

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of NaCl, MgCl2, and CCCP on the
cytoplasmic membrane permeabilization activity of cationic peptides
CP29 (solid), CEME (stippled), and CP26 (striped).
|
|
 |
DISCUSSION |
A combination of appropriate chain length, amino acid
composition, and positioning of apolar and positively charged
residues is required for the antibacterial activity of cationic
antimicrobial peptides; however, the exact nature of this combination
is still under study. Pathak et al. (24) hypothesized that
the amphiphilicity of antimicrobial peptides is the most important
factor governing activity, above mean hydrophobicity and
-helix
content. In another study it was reported that the antimicrobial
activity of the cecropin-melittin hybrid peptides depends on their
helical nature (3). Here, we used the already-established
cecropin-melittin hybrid peptide, CEME, and CEMA, a variant peptide
with two extra amino acids and positive charges in the C terminus, as
the templates for further design. Piers et al. (27) showed
that CEMA was more efficient at binding the divalent cation binding
sites on surface LPS and at destabilizing the outer membrane. However,
CEMA did not display notably better bacterial killing than CEME. In
this study we showed that the additional four residues at the C
terminus of CEMA made it somewhat less
-helical than CEME, which
raised the question as to whether the degree of
-helicity is a
factor in antibacterial activity. CEME was modified to have an increase
in amphipathic
-helical content in its first 14 amino acids,
resulting in CP29. This was accomplished by spacing out the lysine and
hydrophobic residues to better fit a helical-wheel projection, as well
as replacing the glycine residues in the middle of the peptide with threonine, which is more easily accommodated in an
-helix. CP26 was
designed by using CP29 as the parent peptide. Its middle hinge region
was made more amphipathic and flexible by an added alanine, and the C
terminus was modified to become more
-helical and hydrophilic with
the addition of an extra positive charge. CP201 was also based on CP29,
with one less charge and lower hydrophobicity as a result of the two
glycines added to make the central region more flexible, like that of
CEME. CP208 was very similar to CP26, with the main difference being
the substitution of a lysine for the conserved tryptophan residue at
position 2. This peptide was also designed to maintain an
-helical structure.
The CD spectral analysis of these peptides showed that CP29 had the
highest helicity of all the peptides. Although CP26 was designed to
have a more helical C terminus, the changes around the bend region
(i.e., in the vicinity of the proline residue at position 22),
including the additional charge, seemed to have a detrimental effect on
-helix formation. CP201 was similar to CP26 in terms of its CD
spectra. CP208, however, was essentially a random coil in the presence
of liposomes, possibly owing to the lack of the hydrophobic residue
tryptophan, which is an amino acid known to be important for
interaction of proteins with lipid membranes (23). This was
despite the fact that CP208 was designed to have a
-helical structure.
CP26, CEME, CEMA, and CP29 had the same number of amino acids but had
charges ranging from +5 to +7, hydrophobic amino acid contents from 46 to 69%, and
-helix contents ranging from 17 to 57% in lipid
environments. It was thus of interest to note the similarities and
differences between these peptides. All had similar and good activities
against the gram-negative bacteria tested and were able to rapidly kill
logarithmic-phase bacteria. They also demonstrated similar MICs for
antibiotic-resistant mutants of P. aeruginosa, indicating
that the mode of action of these
-helical peptides differs from
those of conventional antibiotics and that these antibiotics are not
effluxed in P. aeruginosa (cf. Neisseria
gonorrhoeae [33]). The increase in the
-helicity of CP29 did not make the peptide more active in vitro. The
MICs of CP26 were also similar, indicating either that the altered bend
region and extra charge did not affect its MIC or that it has a
different killing mechanism. CP201, which fell within the ranges of
most of the physical properties of the above four peptides, was not a
good antibacterial agent, possibly due to the combination of two
detrimental factors, namely, lower hydrophobicity (42%) and lower
charge (+5). CP208, which also had physical properties similar to those
of the four active peptides, had virtually no antibacterial activity,
possibly because it lacked a tryptophan residue required for the
insertion of the peptide into the lipid membrane. This was supported by
the observation that although CP208 was designed to be
-helical, it
was unable to form an
-helix upon interaction with liposomes but was
able to in the presence of SDS.
The ability to resist salt (NaCl is the most predominant salt in vivo)
is important for cationic peptides to function under physiological
conditions. In the case of cystic fibrosis, it has been suggested that
the susceptibility of epithelial antimicrobial peptides (presumably
-structured defensins) to salt antagonism explains the persistence
of chronic P. aeruginosa infections in the lungs of patients
with this disease (13). Lee et al. (20) reported
the NaCl resistance of the tunicate cationic peptide clavanin in
contrast to the
-helical peptides magainin 1 and cecropin P1. It has
been observed that extended indolicidins,
-sheet gramicidins, and
looped and linear bactenecins are all quite salt (KCl) sensitive
(37). Thus, it was of interest to examine the effects of
salts on the activities of our
-helical peptides. There were no
significant changes in the MICs of CEME, CEMA, and CP29 in the presence
of up to 300 mM NaCl, whereas CP26 appeared to be resistant to NaCl
only at concentrations up to 160 mM. An NaCl concentration of 120 mM
has been reported to be present in the environment of the epithelial
cells of a cystic fibrosis patient, which is 30 mM higher than the
level of NaCl that antagonizes the activity of epithelial cationic
peptides (13). Therefore, even CP26 can be described as NaCl
resistant. The differences in activity between CP26 and the other three
peptides are presumably related to differences in flexibility and/or
hydrophobicity. Interestingly, all peptides were relatively more
susceptible to the presence of Mg2+ ions, with a 16-fold
increase in their MICs in the presence of 5 mM Mg2+,
although CEMA was clearly more resistant to physiologically meaningful
(3 mM) divalent cation concentrations. This is unlikely to be due
solely to the valency of the positively charged ion. The ionic strength
of a MgCl2 solution should be only threefold higher than
that of an equivalent NaCl solution, whereas 100-fold-lower Mg2+ concentrations had the same effect as 300 mM
Na+. Presumably, these different effects can be explained
by differential affinities for a binding site on cells, which we
propose here to be on cell surface LPS. Mg2+ has a much
higher affinity for binding to LPS than does Na+
(25). The differential effects of divalent and monovalent
cations were also demonstrated by the results of the cytoplasmic
membrane permeabilization experiments (Fig. 4). However, since
interaction with the outer membrane precedes interaction with the
cytoplasmic membrane, it is likely that it was at this earlier
stage that the peptides were being antagonized. We also examined the
antibacterial activities of these peptides in the presence of alginate,
a model polyanionic polysaccharide intended to represent those found in vivo. This polyanion reduced the activity substantially at modest concentrations, although CP26 tended to be less affected by this polyanion. In addition to in vitro killing, these peptides
demonstrated an ability to work in neutropenic mice.
We have demonstrated here that
-helical peptides with the same
general physical properties, but with small differences in hydrophobicity, amphipathicity, charge, and degree of
-helicity, can
vary substantially in activity, salt resistance, and permeabilizing ability. CP26 and CP29, which differed by only seven amino acids (four
of which were substitutions of one hydrophobic residue for another),
had similar MICs and in vivo activities but substantial differences in
their resistance to salt antagonism and ability to permeabilize the
cytoplasmic membrane. Thus, modest alterations in sequence, and
presumably in three-dimensional structure, can result in substantial
alterations in a peptide's properties.
The best
-helical peptides studied here had good activities and were
resistant to physiological concentrations of salt. These characteristics may prove to be useful in the design of future therapeutic antibacterial drugs.
 |
ACKNOWLEDGMENTS |
This work was financially supported by the Canadian Cystic
Fibrosis Foundation through their SPARx program, by the Canadian Bacterial Diseases Network, and by Micrologix Biotech Inc. R.E.W.H. is
a recipient of the Medical Research Council of Canada Distinguished Scientist award.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, University of British Columbia, #300, 6174 University Blvd., Vancouver, B.C. V6T 1Z3, Canada. Phone: (604) 822-2682. Fax: (604) 822-6041. E-mail: bob{at}cmdr.ubc.ca.
 |
REFERENCES |
| 1.
|
Amsterdam, D.
1996.
Susceptibility testing of antimicrobials in liquid media, p. 52-111.
In
V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams and Wilkins, Baltimore, Md.
|
| 2.
|
Andrade, M. A.,
P. Chacón,
J. J. Merelo, and F. Morán.
1993.
Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network.
Protein Eng.
6:383-390[Abstract/Free Full Text].
|
| 3.
|
Andreu, D.,
R. B. Merrifield,
H. Steiner, and H. G. Boman.
1985.
N-terminal analogues of cecropin A: synthesis, antibacterial activity and conformational properties.
Biochemistry
24:1683-1688[Medline].
|
| 4.
|
Andreu, D.,
J. Ubach,
A. Boman,
B. Wahlin,
D. Wade,
R. B. Merrifield, and H. G. Boman.
1992.
Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.
FEBS Lett.
296:190-199[Medline].
|
| 5.
|
Angus, B. L.,
A. M. Carey,
D. A. Caron,
A. M. B. Kropinski, and R. E. W. Hancock.
1982.
Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant.
Antimicrob. Agents Chemother.
21:299-309[Abstract/Free Full Text].
|
| 6.
|
Bayer, A. S.,
J. Peters,
T. R. Parr, Jr.,
L. Chan, and R. E. W. Hancock.
1987.
Role of -lactamase in in vivo development of ceftazidime resistance in experimental Pseudomonas aeruginosa endocarditis.
Antimicrob. Agents Chemother.
31:253-258[Abstract/Free Full Text].
|
| 7.
|
Boman, H. G.,
D. Wade,
A. Boman,
I. A. Wahlin, and R. B. Merrifield.
1989.
Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids.
FEBS Lett.
259:103-106[Medline].
|
| 8.
|
Christensen, B.,
J. Fink,
R. B. Merrifield, and D. Mauzerall.
1988.
Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes.
Proc. Natl. Acad. Sci. USA
85:5072-5076[Abstract/Free Full Text].
|
| 9.
|
Cociancich, S.,
A. Ghazi,
J. A. Hoffman,
C. Hetrus, and C. Letellier.
1993.
Insect defensin, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus.
J. Biol. Chem.
268:19239-19245[Abstract/Free Full Text].
|
| 10.
|
Falla, T. J.,
D. N. Karunaratne, and R. E. W. Hancock.
1996.
Mode of action of the antimicrobial peptide indolicidin.
J. Biol. Chem.
271:19298-19303[Abstract/Free Full Text].
|
| 11.
|
Fields, P. I.,
E. A. Groisman, and F. Heffron.
1989.
A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells.
Science
243:1059-1062[Abstract/Free Full Text].
|
| 12.
|
Fink, J.,
A. Boman,
H. G. Boman, and R. B. Merrifield.
1989.
Design, synthesis and antibacterial activity of cecropin-like model peptides.
Int. J. Pep. Protein Res.
33:412-421.
|
| 13.
|
Goldman, M. J.,
G. M. Anderson,
E. D. Stolzenberg,
U. P. Kari,
M. Zasloff, and J. M. Wilson.
1997.
Human-beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis.
Cell
88:553-560[Medline].
|
| 14.
|
Gough, M.,
R. E. W. Hancock, and N. M. Kelly.
1996.
Antiendotoxin activity of cationic peptide antimicrobial agents.
Infect. Immun.
64:4922-4927[Abstract].
|
| 15.
|
Hancock, R. E. W., and A. M. Carey.
1979.
Outer membrane of Pseudomonas aeruginosa: heat- and 2-mercaptoethanol-modifiable proteins.
J. Bacteriol.
140:902-910[Abstract/Free Full Text].
|
| 16.
|
Hancock, R. E. W.,
T. Falla, and M. Brown.
1995.
cationic bactericidal peptides.
Adv. Microb. Physiol.
37:136-175.
|
| 17.
|
Hultmark, D.,
H. Steiner,
T. Rasmusen, and H. G. Boman.
1980.
Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia.
Eur. J. Biochem.
106:7-16[Medline].
|
| 18.
|
Inoue, Y.,
K. Sato,
T. Fujii,
K. Hirai,
M. Inoue,
S. Iyobe, and S. Mitsuhashi.
1987.
Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant.
J. Bacteriol.
169:2322-2325[Abstract/Free Full Text].
|
| 19.
|
Juretic, D.,
H. C. Chan,
J. H. Brown,
J. L. Morell,
R. W. Hendler, and H. Westerhoff.
1989.
Magainin 2 amide and analogues, antimicrobial activity, membrane depolarization and susceptibility to proteolysis.
FEBS Lett.
249:219-223[Medline].
|
| 20.
|
Lee, I. H.,
Y. Cho, and R. I. Lehrer.
1997.
Effects of pH and salinity on the antimicrobial properties of clavanins.
Infect. Immun.
65:2898-2903[Abstract].
|
| 21.
|
Lehrer, R. I.,
A. Barton,
K. A. Daher,
S. S. L. Harwig,
T. Ganz, and M. E. Selsted.
1989.
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.
J. Clin. Investig.
84:553-561.
|
| 22.
|
Masuda, N., and S. Ohya.
1992.
Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
36:1847-1851[Abstract/Free Full Text].
|
| 23.
|
Meers, P.
1990.
Location of tryptophans in membrane-bound annexins.
Biochemistry
29:3325-3330[Medline].
|
| 24.
|
Pathak, N.,
R. Salas-Auvert,
R. Ruche,
M.-H. Janna,
D. McCarthy, and R. G. Harrison.
1995.
Comparison of the effects of hydrophobicity, amphiphilicity and alpha helicity on the activities of antimicrobial peptides.
Proteins Struct. Funct. Genet.
22:182-186.
[Medline] |
| 25.
|
Peterson, A. A.,
R. E. W. Hancock, and E. J. McGroarty.
1985.
Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa.
J. Bacteriol.
164:1256-1261[Abstract/Free Full Text].
|
| 26.
|
Peterson, A. A.,
S. W. Fesik, and E. J. McGroarty.
1987.
Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium.
Antimicrob. Agents Chemother.
31:230-237[Abstract/Free Full Text].
|
| 27.
|
Piers, K. L.,
M. H. Brown, and R. E. W. Hancock.
1994.
Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification.
Antimicrob. Agents Chemother.
38:2311-2316[Abstract/Free Full Text].
|
| 28.
|
Piers, K. L., and R. E. W. Hancock.
1994.
The interaction of recombinant cecropin/melittin hybrid peptides with the outer membrane of Pseudomonas aeruginosa.
Mol. Microbiol.
12:951-960[Medline].
|
| 29.
|
Poole, K.,
K. Krebes,
C. McNally, and S. Neshat.
1993.
Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.
J. Bacteriol.
175:7363-7372[Abstract/Free Full Text].
|
| 30.
|
Rella, M., and D. Haas.
1982.
Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of -lactam antibiotics: mapping of chromosomal genes.
Antimicrob. Agents Chemother.
22:242-249[Abstract/Free Full Text].
|
| 31.
|
Sawyer, J. G.,
N. L. Martin, and R. E. W. Hancock.
1988.
Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa.
Infect. Immun.
56:693-698[Abstract/Free Full Text].
|
| 32.
|
Schiffer, M., and A. B. Edmundson.
1967.
Use of helical wheels to represent the structures of protein and to identify segments with helical potential.
Biophys. J.
7:121-135.
|
| 33.
|
Shafer, W. M.,
X.-D. Qu,
A. J. Waning, and R. I. Lehrer.
1998.
Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to resistance/nodulation/division efflux pump family.
Proc. Natl. Acad. Sci. USA
95:1829-1833[Abstract/Free Full Text].
|
| 34.
|
Smith, J. J.,
S. M. Travis,
E. P. Greenburg, and M. J. Welsh.
1996.
Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.
Cell
85:229-236[Medline].
|
| 35.
|
Wade, D.,
D. Andreu,
S. A. Mitchell,
A. M. V. Silveria,
A. Boman,
H. G. Boman, and R. B. Merrifield.
1992.
Antibacterial peptides designed as analogs or hybrids of cecropins and melittin.
Int. J. Pept. Protein Res.
40:429-436[Medline].
|
| 36.
|
Wade, D.,
B. Boman,
B. Wahlin,
C. M. Drain,
D. Andreu,
H. G. Boman, and R. B. Merrifield.
1990.
All-D amino acid-containing channel-forming antibiotic peptides.
Proc. Natl. Acad. Sci. USA
87:4761-4765[Abstract/Free Full Text].
|
| 37.
| Wu, M., E. Maier, R. Benz, and R. E. W. Hancock. Mechanism of interaction of different classes of cationic
antimicrobial peptides with planar bilayers and with the cytoplasmic
membrane of Escherichia coli. Biochemistry, in press.
|
| 38.
| Zhang, L., R. Benz, and R. E. W. Hancock.
Influence of proline residues on the antibacterial and synergistic
activities of -helical peptides. Biochemistry, in press.
|
Antimicrobial Agents and Chemotherapy, July 1999, p. 1542-1548, Vol. 43, No. 7
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Arafah, S., Rosso, M.-L., Rehaume, L., Hancock, R. E. W., Simonet, M., Marceau, M.
(2009). An iron-regulated LysR-type element mediates antimicrobial peptide resistance and virulence in Yersinia pseudotuberculosis. Microbiology
155: 2168-2181
[Abstract]
[Full Text]
-
Tran, D., Tran, P., Roberts, K., Osapay, G., Schaal, J., Ouellette, A., Selsted, M. E.
(2008). Microbicidal Properties and Cytocidal Selectivity of Rhesus Macaque Theta Defensins. Antimicrob. Agents Chemother.
52: 944-953
[Abstract]
[Full Text]
-
Clements, A., Tull, D., Jenney, A. W., Farn, J. L., Kim, S.-H., Bishop, R. E., McPhee, J. B., Hancock, R. E. W., Hartland, E. L., Pearse, M. J., Wijburg, O. L. C., Jackson, D. C., McConville, M. J., Strugnell, R. A.
(2007). Secondary Acylation of Klebsiella pneumoniae Lipopolysaccharide Contributes to Sensitivity to Antibacterial Peptides. J. Biol. Chem.
282: 15569-15577
[Abstract]
[Full Text]
-
Rodriguez-Hernandez, M. J., Saugar, J., Docobo-Perez, F., de la Torre, B. G., Pachon-Ibanez, M. E., Garcia-Curiel, A., Fernandez-Cuenca, F., Andreu, D., Rivas, L., Pachon, J.
(2006). Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother
58: 95-100
[Abstract]
[Full Text]
-
Balakrishna, R., Wood, S. J., Nguyen, T. B., Miller, K. A., Suresh Kumar, E. V. K., Datta, A., David, S. A.
(2006). Structural Correlates of Antibacterial and Membrane-Permeabilizing Activities in Acylpolyamines. Antimicrob. Agents Chemother.
50: 852-861
[Abstract]
[Full Text]
-
Gueguen, Y., Herpin, A., Aumelas, A., Garnier, J., Fievet, J., Escoubas, J.-M., Bulet, P., Gonzalez, M., Lelong, C., Favrel, P., Bachere, E.
(2006). Characterization of a Defensin from the Oyster Crassostrea gigas: RECOMBINANT PRODUCTION, FOLDING, SOLUTION STRUCTURE, ANTIMICROBIAL ACTIVITIES, AND GENE EXPRESSION. J. Biol. Chem.
281: 313-323
[Abstract]
[Full Text]
-
Deslouches, B., Islam, K., Craigo, J. K., Paranjape, S. M., Montelaro, R. C., Mietzner, T. A.
(2005). Activity of the De Novo Engineered Antimicrobial Peptide WLBU2 against Pseudomonas aeruginosa in Human Serum and Whole Blood: Implications for Systemic Applications. Antimicrob. Agents Chemother.
49: 3208-3216
[Abstract]
[Full Text]
-
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., Hancock, R. E. W.
(2005). Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol.
77: 451-459
[Abstract]
[Full Text]
-
Yenugu, S., Richardson, R. T., Sivashanmugam, P., Wang, Z., O'Rand, M. G., French, F. S., Hall, S. H.
(2004). Antimicrobial Activity of Human EPPIN, an Androgen-Regulated, Sperm-Bound Protein with a Whey Acidic Protein Motif. Biol. Reprod.
71: 1484-1490
[Abstract]
[Full Text]
-
Karim, C. B., Kirby, T. L., Zhang, Z., Nesmelov, Y., Thomas, D. D.
(2004). Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone. Proc. Natl. Acad. Sci. USA
101: 14437-14442
[Abstract]
[Full Text]
-
Yenugu, S., Hamil, K. G., Radhakrishnan, Y., French, F. S., Hall, S. H.
(2004). The Androgen-Regulated Epididymal Sperm-Binding Protein, Human {beta}-Defensin 118 (DEFB118) (Formerly ESC42), Is an Antimicrobial {beta}-Defensin. Endocrinology
145: 3165-3173
[Abstract]
[Full Text]
-
Bucki, R., Pastore, J. J., Randhawa, P., Vegners, R., Weiner, D. J., Janmey, P. A.
(2004). Antibacterial Activities of Rhodamine B-Conjugated Gelsolin-Derived Peptides Compared to Those of the Antimicrobial Peptides Cathelicidin LL37, Magainin II, and Melittin. Antimicrob. Agents Chemother.
48: 1526-1533
[Abstract]
[Full Text]
-
Park, I. Y., Cho, J. H., Kim, K. S., Kim, Y.-B., Kim, M. S., Kim, S. C.
(2004). Helix Stability Confers Salt Resistance upon Helical Antimicrobial Peptides. J. Biol. Chem.
279: 13896-13901
[Abstract]
[Full Text]
-
Concannon, S. P., Crowe, T. D., Abercrombie, J. J., Molina, C. M., Hou, P., Sukumaran, D. K., Raj, P. A., Leung, K. -P.
(2003). Susceptibility of oral bacteria to an antimicrobial decapeptide. J Med Microbiol
52: 1083-1093
[Abstract]
[Full Text]
-
Jang, W. S., Kim, C. H., Kim, K. N., Park, S. Y., Lee, J. H., Son, S. M., Lee, I. H.
(2003). Biological Activities of Synthetic Analogs of Halocidin, an Antimicrobial Peptide from the Tunicate Halocynthia aurantium. Antimicrob. Agents Chemother.
47: 2481-2486
[Abstract]
[Full Text]
-
Yeaman, M. R., Yount, N. Y.
(2003). Mechanisms of Antimicrobial Peptide Action and Resistance. Pharmacol. Rev.
55: 27-55
[Abstract]
[Full Text]
-
Tsukiyama, R.-I., Katsura, H., Tokuriki, N., Kobayashi, M.
(2002). Antibacterial Activity of Licochalcone A against Spore-Forming Bacteria. Antimicrob. Agents Chemother.
46: 1226-1230
[Abstract]
[Full Text]
-
Saugar, J. M., Alarcon, T., Lopez-Hernandez, S., Lopez-Brea, M., Andreu, D., Rivas, L.
(2002). Activities of Polymyxin B and Cecropin A-Melittin Peptide CA(1-8)M(1-18) against a Multiresistant Strain of Acinetobacter baumannii. Antimicrob. Agents Chemother.
46: 875-878
[Abstract]
[Full Text]
-
Chicharro, C., Granata, C., Lozano, R., Andreu, D., Rivas, L.
(2001). N-Terminal Fatty Acid Substitution Increases the Leishmanicidal Activity of CA(1-7)M(2-9), a Cecropin-Melittin Hybrid Peptide. Antimicrob. Agents Chemother.
45: 2441-2449
[Abstract]
[Full Text]
-
Macfarlane, E. L. A., Kwasnicka, A., Hancock, R. E. W.
(2000). Role of Pseudomonas aeruginosa PhoP-PhoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology
146: 2543-2554
[Abstract]
[Full Text]
-
Friedrich, C. L., Moyles, D., Beveridge, T. J., Hancock, R. E. W.
(2000). Antibacterial Action of Structurally Diverse Cationic Peptides on Gram-Positive Bacteria. Antimicrob. Agents Chemother.
44: 2086-2092
[Abstract]
[Full Text]
-
Hancock, R. E. W., Scott, M. G.
(2000). The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. USA
97: 8856-8861
[Abstract]
[Full Text]
-
Jia, X., Patrzykat, A., Devlin, R. H., Ackerman, P. A., Iwama, G. K., Hancock, R. E. W.
(2000). Antimicrobial Peptides Protect Coho Salmon from Vibrio anguillarum Infections. Appl. Environ. Microbiol.
66: 1928-1932
[Abstract]
[Full Text]
-
Silvestro, L., Weiser, J. N., Axelsen, P. H.
(2000). Antibacterial and Antimembrane Activities of Cecropin A in Escherichia coli. Antimicrob. Agents Chemother.
44: 602-607
[Abstract]
[Full Text]
-
Friedrich, C. L., Rozek, A., Patrzykat, A., Hancock, R. E. W.
(2001). Structure and Mechanism of Action of an Indolicidin Peptide Derivative with Improved Activity against Gram-positive Bacteria. J. Biol. Chem.
276: 24015-24022
[Abstract]
[Full Text]